Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Item

Notes

OOOs

  • Steven OOO: Oct 30 (or 31st)

  • Gretl OOO: 11/2-11/6, 11/28-12/1/2023

  • Anne OOO: 10/25

  • Sarah OOO: Nov 9

  • APHL closed Veteran’s Day: Nov 10

TB LWP: Issue Log

Published Link: https://app.smartsheet.com/b/publish?EQBCT=1136271a8d2e4fa184ebc0833df46742

Smartsheet: https://app.smartsheet.com/sheets/8q4pGFcfXc4mmgCw5Q4CQ43j93G6ChHCjxQ5pGm1

  • LWP Specimen Source Mapping: Needs to be extracted/conversion/translations from SL

    • Due date: Is a dependency for assay development, would like to review prior to mapping specimen source

TB Testing Updates Target Deadlines

  • CDPH: Validation schedule for expected TB Testing:

    • tNGS should be available for ordering in StarLims Production by Jan 1, 2024

    • WGS: should be available for ordering in StarLims Production by October 1, 2023

    • PSQ: Will no longer be available for ordering as of December 31, 2023

TB LWP: WGS & tNGS TRF Updates

TB Mapping Documentation

  • Review/update TB TRF > CDPH Starlims Mapping

    • See Mapping spreadsheet--any follow up items?

    • Pending confirmation from ICC of Specimen Sources mappings list and any associated transformations/updates applied in SL

    • CDPH:

      • TB: Steven Yu: Reviewed list of specimen sources with Amy from MDL LWP--this is different from the list on the TB LWP

      • ICC: Can extract the list--will try to complete/compile mappings by 11/1

      • Ras Client: TB would like to handle it differently from MDL

        • icc: Can customize for TB,

          • MDL--maps to lab director, then general tab

        • SY: If no lab director, would default from general tab (can keep that logic for right now)

          • Phone/fax number: Thinks it it being pulled from general tab

          • SY: Will keep it as it is in (currently in SB for MDL)--may change later

        • What is universally implemented for MDL/VRDL AND TB?

          • ICC: Anything that involves SL/LCs would be universally applied (Forms are segregated in SL--every form is different)

          • APHL: Provide universal changes which may be applied to both MDL/VRDL AND TB LWPs for review to Steven prior to applying to TB LWP so we have consensus for changes and and awareness of changes, potential impact, and historic documentation

Questions

Next Steps & Action Items

  • ICC: Provide current list of TB Specimen Sources and any associated mappings for review: 11/1

  • ICC: Develop updated TRF for review in DEV/QC1: Target: 10/31/23

  • APHL: ICC to provide summary of universal changes which may be applied to both MDL/VRDL AND TB LWPs for review to Steven/TB Team prior to applying to TB LWP so we have consensus and awareness of changes, potential impact, and historic documentation

Action items

  • APHL: Assess ICC resource availability, determine development, deployment schedule

...